The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40

被引:23
作者
Carr, JA [1 ]
Rogerson, JA
Mulqueen, MJ
Roberts, NA
Nash, AA
机构
[1] Roche Discovery Welwyn, Dept Virol, Welwyn Garden City AL7 3AY, Herts, England
[2] Univ Edinburgh, Royal Dick Sch Vet Studies, Dept Vet Pathol, Edinburgh EH9 1QH, Midlothian, Scotland
关键词
D O I
10.1089/107999099313082
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Biologically active interleukin-12 (IL-12), comprising a 40 kDa subunit (p40) covalently linked to a 35 kDa subunit (p35), is produced in response to a range of infectious stimuli. Here, me demonstrate that mice deficient in either IL-12 p30 (p40(-/-)) or IL-12 p35 (p35(-/-)) are susceptible to murine cytomegalovirus (MCMV) infection in terms of survival (Balb/c p35(-/-)) and viral clearance (Balb/c p35(-/-) and Balb/c p30-/-), and this susceptibility may be correlated to a deficiency in serum interferon-gamma (IFN-gamma) levels. These data support a role for endogenous IL-12 in controlling MCMV infection. The IL-12 p30 subunit is produced in excess of IL-12 p35, and to date the function of the excess endogenous p40 has been assumed to be one of IL-12 antagonism, as demonstrated by experiments with exogenous p40 both in vivo and in vitro, We show that Balb/c p35(-/-) alone are significantly compromised in survival of a sublethal infection and in clearance of virus from the spleen. These mice produce a very early IFN-gamma spike (8 h after infection) and an aberrant tumor necrosis factor-alpha (TNF-alpha) spike (day 2 after infection). MCR IV infection has revealed an altered Balb/c p35(-/-) phenotype compared with Balb/c p40(-/-), and this indicates that endogenous p30 may have an activity independent of and additional to IL-12 antagonism in vivo.
引用
收藏
页码:1145 / 1152
页数:8
相关论文
共 43 条
  • [1] BI ZB, 1995, J IMMUNOL, V155, P5684
  • [2] Interleukin-12 exhibits potent antiviral activity in experimental herpesvirus infections
    Carr, JA
    Rogerson, J
    Mulqueen, MJ
    Roberts, NA
    Booth, RFG
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (10) : 7799 - 7803
  • [3] Interleukin-12 inhibits hepatitis B virus replication in transgenic mice
    Cavanaugh, VJ
    Guidotti, LG
    Chisari, FV
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (04) : 3236 - 3243
  • [4] ENHANCING EFFECT OF NATURAL-KILLER-CELL STIMULATORY FACTOR (NKSF/INTERLEUKIN-12) ON CELL-MEDIATED CYTOTOXICITY AGAINST TUMOR-DERIVED AND VIRUS-INFECTED CELLS
    CHEHIMI, J
    VALIANTE, NM
    DANDREA, A
    RENGARAJU, M
    ROSADO, Z
    KOBAYASHI, M
    PERUSSIA, B
    WOLF, SF
    STARR, SE
    TRINCHIERI, G
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (08) : 1826 - 1830
  • [5] NATURAL-KILLER (NK) CELL STIMULATORY FACTOR INCREASES THE CYTOTOXIC ACTIVITY OF NK CELLS FROM BOTH HEALTHY DONORS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PATIENTS
    CHEHIMI, J
    STARR, SE
    FRANK, I
    RENGARAJU, M
    JACKSON, SJ
    LLANES, C
    KOBAYASHI, M
    PERUSSIA, B
    YOUNG, D
    NICKBARG, E
    WOLF, SF
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) : 789 - 796
  • [6] IMPAIRED INTERLEUKIN-12 PRODUCTION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    CHEHIMI, J
    STARR, SE
    FRANK, I
    DANDREA, A
    MA, XJ
    MACGREGOR, RR
    SENNELIER, J
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) : 1361 - 1366
  • [7] Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis
    Cooper, AM
    Magram, J
    Ferrante, J
    Orme, IM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) : 39 - 45
  • [8] INTERLEUKIN-12 GENE-EXPRESSION AFTER VIRAL-INFECTION IN THE MOUSE
    COUTELIER, JP
    VANBROECK, J
    WOLF, SF
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (03) : 1955 - 1958
  • [9] PRODUCTION OF NATURAL-KILLER-CELL STIMULATORY FACTOR (INTERLEUKIN-12) BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS
    DANDREA, A
    RENGARAJU, M
    VALIANTE, NM
    CHEHIMI, J
    KUBIN, M
    ASTE, M
    CHAN, SH
    KOBAYASHI, M
    YOUNG, D
    NICKBARG, E
    CHIZZONITE, R
    WOLF, SF
    TRINCHIERI, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1387 - 1398
  • [10] Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin
    Devergne, O
    Birkenbach, M
    Kieff, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) : 12041 - 12046